AVIR (STOCKS)
Atea Pharmaceuticals, Inc. Common Stock
$5.070000
+0.010000 (+0.20%)
Prev close: $5.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jean-Pierre Sommadossi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $445.34M
- Employees
- 56
- P/E (TTM)
- -2.42
- P/B (TTM)
- 1.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $243.06M |
| Benefits Costs and Expenses | $204.06M |
| Costs And Expenses | $204.06M |
| Operating Expenses | $203.45M |
| Depreciation and Amortization | $6.00M |
| Research and Development | $184.26M |
| Other Operating Expenses | $15.27M |
| Operating Income/Loss | $39.61M |
| Income/Loss From Continuing Operations After Tax | $38.59M |
| Income/Loss From Continuing Operations Before Tax | $39.01M |
| Income Tax Expense/Benefit | $419.00K |
| Net Income/Loss | $38.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $38.59M |
| Net Income/Loss Available To Common Stockholders, Basic | $38.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.17 |
| Basic Average Shares | 472,197,608 |
| Assets | $165.19M |
| Current Assets | $116.69M |
| Cash | $64.00M |
| Other Current Assets | $52.69M |
| Noncurrent Assets | $48.49M |
| Fixed Assets | $5.51M |
| Intangible Assets | $2.46M |
| Other Non-current Assets | $40.53M |
| Liabilities | $82.81M |
| Current Liabilities | $73.11M |
| Accounts Payable | $16.97M |
| Wages | $2.69M |
| Other Current Liabilities | $53.45M |
| Noncurrent Liabilities | $9.71M |
| Equity | $82.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $82.37M |
| Liabilities And Equity | $165.19M |
| Net Cash Flow From Operating Activities | $33.98M |
| Net Cash Flow From Operating Activities, Continuing | $33.98M |
| Net Cash Flow From Investing Activities | -$7.23M |
| Net Cash Flow From Investing Activities, Continuing | -$7.23M |
| Net Cash Flow From Financing Activities | $4.06M |
| Net Cash Flow From Financing Activities, Continuing | $4.06M |
| Net Cash Flow | $30.82M |
| Net Cash Flow, Continuing | $30.82M |
| Comprehensive Income/Loss | $38.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $38.59M |
| Other Comprehensive Income/Loss | $38.59M |